{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:54:08Z","timestamp":1780649648651,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11102-023-01321-8","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T01:01:32Z","timestamp":1685322092000},"page":"402-410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Importance of 24\u00a0h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings"],"prefix":"10.1007","volume":"26","author":[{"given":"Paula","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Muxfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-3192","authenticated-orcid":false,"given":"Leandro","family":"Kasuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"issue":"1","key":"1321_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","volume":"40","author":"MR Gadelha","year":"2019","unstructured":"Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40(1):268\u2013332","journal-title":"Endocr Rev"},{"issue":"1","key":"1321_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102\u2013152","journal-title":"Endocr Rev"},{"issue":"7","key":"1321_CR3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/HJH.0000000000000962","volume":"34","author":"F Costenaro","year":"2016","unstructured":"Costenaro F, Martin A, Horn RF, Czepielewski MA, Rodrigues TC (2016) Role of ambulatory blood pressure monitoring in patients with acromegaly. J Hypertens 34(7):1357\u20131363","journal-title":"J Hypertens"},{"issue":"2","key":"1321_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1365-2265.1998.3611177.x","volume":"48","author":"G Minniti","year":"1998","unstructured":"Minniti G, Moroni C, Jaffrain-Rea ML, Bondanini F, Gulino A, Cassone R et al (1998) Prevalence of hypertension in acromegalic patients: clinical measurement versus 24-hour ambulatory blood pressure monitoring. Clin Endocrinol 48(2):149\u2013152","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1321_CR5","first-page":"193","volume":"85","author":"A Colao","year":"2000","unstructured":"Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P et al (2000) Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 85(1):193\u2013199","journal-title":"J Clin Endocrinol Metab"},{"key":"1321_CR6","volume-title":"Braunwald\u2019s heart disease: a textbook of cardiovascular medicine","author":"DLZD Mann","year":"2015","unstructured":"Mann DLZD, Libby P, Bonow RO, Braunwald E (2015) Braunwald\u2019s heart disease: a textbook of cardiovascular medicine, 9th edn. Elsevier, Berlin","edition":"9"},{"key":"1321_CR7","first-page":"6","volume":"103","author":"LSGTA Sara","year":"2014","unstructured":"Sara LSGTA, Shiozaki AA, Villa AV, Oliveira AC, Albuquerque AS et al (2014) II diretriz da Resson\u00e2ncia Magn\u00e9tica e Tomografia Computadorizada Cardiovascular da Sociedade Brasileira de Cardiologia e do Col\u00e9gio Brasilerio de Radiologia. Arq Iras Cardiol 103:6","journal-title":"Arq Iras Cardiol"},{"issue":"6 Suppl 3","key":"1321_CR8","first-page":"1","volume":"103","author":"L Sara","year":"2014","unstructured":"Sara L, Szarf G, Tachibana A, Shiozaki AA, Villa AV, de Oliveira AC et al (2014) II guidelines on cardiovascular magnetic resonance and computed tomography of the Brazilian Society of Cardiology and the Brazilian College of Radiology. Arq Bras Cardiol 103(6 Suppl 3):1\u201386","journal-title":"Arq Bras Cardiol"},{"issue":"4","key":"1321_CR9","first-page":"1047","volume":"82","author":"R Lopez-Velasco","year":"1997","unstructured":"Lopez-Velasco R, Escobar-Morreale HF, Vega B, Villa E, Sancho JM, Moya-Mur JL et al (1997) Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension? J Clin Endocrinol Metab 82(4):1047\u20131053","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1321_CR10","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951","journal-title":"J Clin Endocrinol Metab"},{"key":"1321_CR11","first-page":"1","volume-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization technical report series","author":"World Health Organization","year":"2000","unstructured":"World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization technical report series, vol 894. World Health Organization, Geneva, pp 1\u2013253"},{"issue":"Suppl 1","key":"1321_CR12","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association (2021) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 44(Suppl 1):S15\u2013S33","journal-title":"Diabetes Care"},{"issue":"6","key":"1321_CR13","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C et al (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71(6):1269\u20131324","journal-title":"Hypertension"},{"issue":"10","key":"1321_CR14","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al (2018) 2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 36(10):1953\u20132041","journal-title":"J Hypertens"},{"issue":"11","key":"1321_CR15","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1097\/HJH.0000000000002625","volume":"38","author":"RH Schneider","year":"2020","unstructured":"Schneider RH, Salerno J, Brook RD (2020) 2020 International Society of Hypertension global hypertension practice guidelines\u2014lifestyle modification. J Hypertens 38(11):2340\u20132341","journal-title":"J Hypertens"},{"issue":"4","key":"1321_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00126097-200008000-00007","volume":"5","author":"CR Jones","year":"2000","unstructured":"Jones CR, Taylor K, Chowienczyk P, Poston L, Shennan AH (2000) A validation of the Mobil O Graph (version 12) ambulatory blood pressure monitor. Blood Press Monit 5(4):233\u2013238","journal-title":"Blood Press Monit"},{"issue":"7","key":"1321_CR17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/HJH.0000000000000221","volume":"32","author":"G Parati","year":"2014","unstructured":"Parati G, Stergiou G, O\u2019Brien E, Asmar R, Beilin L, Bilo G et al (2014) European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32(7):1359\u20131366","journal-title":"J Hypertens"},{"issue":"12","key":"1321_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ehjci\/jez232","volume":"20","author":"SE Petersen","year":"2019","unstructured":"Petersen SE, Khanji MY, Plein S, Lancellotti P, Bucciarelli-Ducci C (2019) European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. Eur Heart J Cardiovasc Imaging 20(12):1321\u20131331","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"1321_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.hlc.2006.09.006","volume":"16","author":"CB Marcu","year":"2007","unstructured":"Marcu CB, Nijveldt R, Beek AM, Van Rossum AC (2007) Delayed contrast enhancement magnetic resonance imaging for the assessment of cardiac disease. Heart Lung Circ 16(2):70\u201378","journal-title":"Heart Lung Circ"},{"issue":"6","key":"1321_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.20945\/2359-3997000000193","volume":"63","author":"L Kasuki","year":"2019","unstructured":"Kasuki L, Rocha PDS, Lamback EB, Gadelha MR (2019) Determinants of morbidities and mortality in acromegaly. Arch Endocrinol Metab 63(6):630\u2013637","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"1321_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/BF03345478","volume":"22","author":"M Terzolo","year":"1992","unstructured":"Terzolo M, Matrella C, Boccuzzi A, Luceri S, Borriero M, Reimondo G et al (1992) Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features. J Endocrinol Investig 22(1):48\u201354","journal-title":"J Endocrinol Investig"},{"issue":"S1","key":"1321_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3233\/THC-199006","volume":"27","author":"ZA Altikardes","year":"2019","unstructured":"Altikardes ZA, Kayikli A, Korkmaz H, Erdal H, Baba AF, Fak AS (2019) A novel method for dipper\/non-dipper pattern classification in hypertensive and non-diabetic patients. Technol Health Care 27(S1):47\u201357","journal-title":"Technol Health Care"},{"key":"1321_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/1874306401206010028","volume":"6","author":"D Hernandez-Gordillo","year":"2012","unstructured":"Hernandez-Gordillo D, Ortega-Gomez Mdel R, Galicia-Polo L, Castorena-Maldonado A, Vergara-Lopez A, Guillen-Gonzalez MA et al (2012) Sleep apnea in patients with acromegaly. Frequency, characterization and positive pressure titration. Open Respir Med J 6:28\u201333","journal-title":"Open Respir Med J"},{"issue":"4","key":"1321_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1530\/EJE-07-0753","volume":"158","author":"FR van Haute","year":"2008","unstructured":"van Haute FR, Taboada GF, Correa LL, Lima GA, Fontes R, Riello AP et al (2008) Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur J Endocrinol 158(4):459\u2013465","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1321_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.endonu.2015.05.007","volume":"62","author":"R Sanchez-Ortiga","year":"2015","unstructured":"Sanchez-Ortiga R, Climent V, Sanchez-Tejada L, Candela A, Pico A (2015) Severe sleep apnea-hypopnea syndrome is related to left ventricle dysfunction and hypertrophy in acromegalic patients. Endocrinol Nutr 62(8):366\u2013372","journal-title":"Endocrinol Nutr"},{"issue":"2","key":"1321_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2165\/00129784-200505020-00001","volume":"5","author":"NA Collop","year":"2005","unstructured":"Collop NA (2005) Obstructive sleep apnea: what does the cardiovascular physician need to know? Am J Cardiovasc Drugs 5(2):71\u201381","journal-title":"Am J Cardiovasc Drugs"},{"issue":"9918","key":"1321_CR27","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0140-6736(13)60734-5","volume":"383","author":"AS Jordan","year":"2014","unstructured":"Jordan AS, McSharry DG, Malhotra A (2014) Adult obstructive sleep apnoea. Lancet 383(9918):736\u2013747","journal-title":"Lancet"},{"key":"1321_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.smrv.2016.10.004","volume":"36","author":"HY Chiu","year":"2017","unstructured":"Chiu HY, Chen PY, Chuang LP, Chen NH, Tu YK, Hsieh YJ et al (2017) Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: a bivariate meta-analysis. Sleep Med Rev 36:57\u201370","journal-title":"Sleep Med Rev"},{"issue":"1","key":"1321_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1573402112666160114093307","volume":"12","author":"H Sawatari","year":"2016","unstructured":"Sawatari H, Chishaki A, Ando SI (2016) The epidemiology of sleep disordered breathing and hypertension in various populations. Curr Hypertens Rev 12(1):12\u201317","journal-title":"Curr Hypertens Rev"},{"issue":"7","key":"1321_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/hr.2009.73","volume":"32","author":"K Kario","year":"2009","unstructured":"Kario K (2009) Obstructive sleep apnea syndrome and hypertension: mechanism of the linkage and 24-h blood pressure control. Hypertens Res 32(7):537\u2013541","journal-title":"Hypertens Res"},{"key":"1321_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/NSS.S148543","volume":"10","author":"O Marrone","year":"2018","unstructured":"Marrone O, Bonsignore MR (2018) Blood-pressure variability in patients with obstructive sleep apnea: current perspectives. Nat Sci Sleep 10:229\u2013242","journal-title":"Nat Sci Sleep"},{"issue":"691","key":"1321_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3399\/bjgp20X708053","volume":"70","author":"NR Jones","year":"2020","unstructured":"Jones NR, McCormack T, Constanti M, McManus RJ (2020) Diagnosis and management of hypertension in adults: NICE guideline update 2019. Br J Gen Pract 70(691):90\u201391","journal-title":"Br J Gen Pract"},{"issue":"4","key":"1321_CR33","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/HYPERTENSIONAHA.120.15859","volume":"76","author":"JB Cohen","year":"2020","unstructured":"Cohen JB (2020) Masked hypertension: fragile in more ways than one. Hypertension 76(4):1079\u20131080","journal-title":"Hypertension"},{"issue":"7","key":"1321_CR34","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/ajh\/hpu002","volume":"27","author":"J Brguljan-Hitij","year":"2014","unstructured":"Brguljan-Hitij J, Thijs L, Li Y, Hansen TW, Boggia J, Liu YP et al (2014) Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure. Am J Hypertens 27(7):956\u2013965","journal-title":"Am J Hypertens"},{"issue":"6","key":"1321_CR35","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1507\/endocrj.42.781","volume":"42","author":"H Ohtsuka","year":"1995","unstructured":"Ohtsuka H, Komiya I, Aizawa T, Yamada T (1995) Hypertension in acromegaly: hereditary hypertensive factor produces hypertension by enhancing IGF-I production. Endocr J 42(6):781\u2013787","journal-title":"Endocr J"},{"issue":"4","key":"1321_CR36","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1365-2265.2005.02370.x","volume":"63","author":"G Vitale","year":"2005","unstructured":"Vitale G, Pivonello R, Auriemma RS, Guerra E, Milone F, Savastano S et al (2005) Hypertension in acromegaly and in the normal population: prevalence and determinants. Clin Endocrinol 63(4):470\u2013476","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1321_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/EJE-12-0084","volume":"167","author":"M Arosio","year":"2012","unstructured":"Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L et al (2012) Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol 167(2):189\u2013198","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1321_CR38","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1161\/HYPERTENSIONAHA.113.03057","volume":"63","author":"AE Schutte","year":"2014","unstructured":"Schutte AE, Volpe M, Tocci G, Conti E (2014) Revisiting the relationship between blood pressure and insulin-like growth factor-1. Hypertension 63(5):1070\u20131077","journal-title":"Hypertension"},{"key":"1321_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12968-015-0176-3","volume":"17","author":"TA Treibel","year":"2015","unstructured":"Treibel TA, Zemrak F, Sado DM, Banypersad SM, White SK, Maestrini V et al (2015) Extracellular volume quantification in isolated hypertension\u2014changes at the detectable limits? J Cardiovasc Magn Reson 17:74","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"1321_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1365-2265.2007.03047.x","volume":"68","author":"F Bogazzi","year":"2008","unstructured":"Bogazzi F, Lombardi M, Strata E, Aquaro G, Di Bello V, Cosci C et al (2008) High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients with untreated active acromegaly: an in vivo study using magnetic resonance imaging. Clin Endocrinol 68(3):361\u2013368","journal-title":"Clin Endocrinol"},{"issue":"6","key":"1321_CR41","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s11102-016-0749-7","volume":"19","author":"L Warszawski","year":"2016","unstructured":"Warszawski L, Kasuki L, Sa R, Dos Santos Silva CM, Volschan I, Gottlieb I et al (2016) Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-naive acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment. Pituitary 19(6):582\u2013589","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01321-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-023-01321-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01321-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T04:14:29Z","timestamp":1690949669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-023-01321-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1007\/s11102-023-01321-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2491932\/v1","asserted-by":"object"}]},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"assertion":[{"value":"14 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.R.G. has served as an advisory board member for Ipsen, Novartis Pharmaceuticals, Novo Nordisk, Re-cordati Rare Diseases and Crinetics Pharmaceuticals; as a research investigator for Crinetics Pharmaceuticals, Recordati Rare Diseases and Novartis Pharmaceuticals; and as a speaker for Crinetics Pharmaceuticals, Novartis Pharmaceuticals, Ipsen, Novo Nordisk and Recordati Rare Diseases. L.K. has received speaker fees from Novartis and Ipsen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of HUCFF\/UFRJ (3. 858. 071) and Faculdade de Medicina da UFRJ and all patients signed written informed consent forms.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}